CN102166329B - Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof - Google Patents
Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof Download PDFInfo
- Publication number
- CN102166329B CN102166329B CN2010101288342A CN201010128834A CN102166329B CN 102166329 B CN102166329 B CN 102166329B CN 2010101288342 A CN2010101288342 A CN 2010101288342A CN 201010128834 A CN201010128834 A CN 201010128834A CN 102166329 B CN102166329 B CN 102166329B
- Authority
- CN
- China
- Prior art keywords
- grams
- chronic hepatitis
- radix
- medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating leukopenia caused by chronic hepatitis B or interferon treatment for treating chronic hepatitis B and a preparation method thereof. The medicine is characterized by being prepared from the following important ingredients: 20 to 30 grams of astragalus root, 6 to 10 grams of Chinese angelica, 8 to 12 grams of common burreed rhizome, 8 to 12 grams of curcuma phaeocaulis valeton, 8 to 12 grams ofprepared rehmannia root, 8 to 12 grams of white paeony root, 8 to 12 grams of hairy asiabell root, and 3 to 5 grams of fried liquorice. The preparation method of the medicine comprises following steps of cleaning the above ingredients, sieving, refining honey, and then, producing medicinal pills. The medicine has advantages of simpleness in preparation, convenience in taking, excellent and durable curative effect, no toxic or side effects, and low cost, and is especially suitable for treating patients with leukopenia caused by chronic hepatitis B or interferon treatment for treating chronic hepatitis B.
Description
Technical field:
The present invention relates to a kind of Chinese herbal medicine, particularly a kind of treatment chronic hepatitis B or trouble chronic hepatitis B are with leukopenic medicine due to the interferon therapy and preparation method thereof.
Background technology:
Chronic hepatitis B is one of common chronic infectious disease of China, and serious harm people ' s health, leukopenia are the common situation in the therapeutic process that reaches in its pathogenic process.Leukopenia is meant that the PBL counting continues to be lower than normal value 4 * 10
9/ L, its paathogenic factor is a lot, like ionizing radiation, chemical toxicant (like benzene etc.), Cytotoxic drugs, malnutrition, malignant tumor, leukemia, viral hepatitis etc.Wherein, Majority is optimum process; But person due to (the most common is adverse Reaction of Interferon) in chronic hepatitis B and the therapeutic process thereof; Single still effective when just sending out with leucogen, batilol, DIYU SHENGBAI PIAN etc., do not send out the many unsatisfactory curative effects of person again, and the said medicine composition is single, price is higher, curative effect is difficult for lastingly.
Summary of the invention:
The object of the invention be exactly to provide a kind of make simple, taking convenience, evident in efficacy and lasting, have no side effect, cheap treatment chronic hepatitis B or suffer from chronic hepatitis B with leukopenic medicine due to the interferon therapy and preparation method thereof.
The objective of the invention is to realize like this: a kind of treatment chronic hepatitis B or trouble chronic hepatitis B is characterized in that it mainly is grouped into by following one-tenth: Radix Astragali 20-30g, Radix Angelicae Sinensis 6-10g, triangular 8-12g, Rhizoma Curcumae 8-12g, Radix Rehmanniae Preparata 8-12g, Radix Paeoniae Alba 8-12g, Radix Codonopsis 8-12g, Radix Glycyrrhizae Preparata 3-5g with leukopenic medicine due to the interferon therapy and preparation method thereof.
Method for preparing of the present invention may further comprise the steps:
1) cleans: raw material is mixed, clean up with clear water;
2) sieve: cleaned raw material is put into drying baker dry, grind into powder then, reuse 100 purpose sieves sieve raw material, and the medicamental pulverata that granule is little filters out, and for future use, grinding into powder again that granule is big sieved;
3) refining Mel: Mel is put into pot with the low baking temperature refining, coagulate like the maltosemalt sugar shape, the not order of stirring is burnt, and the addition of Mel is 1 times of raw-material weight;
4) process pill: the Mel of refining is mixed with above-mentioned medicamental pulverata rubs by evenly, placement pact half an hour, rub once more by, the honeyed pill of processing about 6g gets final product.
The present invention also can be made into medicamental pulverata electuary, capsule.
The major function of each component of the present invention:
The Radix Astragali: tonifying Qi and lifting yang, benefiting QI for strengthening the superficies, inducing diuresis to remove edema, holder skin ulcer granulation promoting are monarch drug; Contain glycoside, polysaccharide, aminoacid and trace element etc.; Have Ramulus Uncariae cum Uncis alkali, isorhynchophylline etc., the Ramulus Uncariae Cum Uncis decoct is injected to mouse peritoneal, can produce tangible sedation; Its ethanol extract can be prevented the outbreak of Cavia porcellus epilepsy reaction, and the irritability of maincenter motor analyzer is increased has certain inhibitory action.
Radix Angelicae Sinensis: suppressing the hyperactive liver and subsiding YANG, liver heat removing and eyesight improving, with Ramulus Uncariae Cum Uncis be monarch drug altogether, the iodine of carbonated calcium, organic matter and magnesium, ferrum, silicate, phosphate, chloride and denier has sedation, too much gastric acid under one's belt can neutralize.
Radix Codonopsis: resuscitation inducing and mind tranquilizing, removing dampness to restore normal function of the stomach are ministerial drug, contain volatile oil, aminoacid, organic acid and saccharide, and its water decoction, volatile oil have sedation, and water decoction has anticonvulsant action.
Radix Rehmanniae Preparata: drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI are ministerial drug; Contain glycoside, several amino acids, volatile oil, Saponin, choline etc., coughing centre is had sedation, can remove bronchospasm; And bronchus secretion is reduced and Antitussive and Expectorant Effect is arranged; Can suppress vomiting center and preventing or arresting vomiting, it is intrinsic pressure that decoct can reduce lagophthalmos, and the stopping nausea and vomiting by lowering the adverse flow of QI effect is better behind the processed with Rhizoma Zingiberis Recens.
The Radix Paeoniae Alba: dispelling wind and heat pathogens, suppressing the hyperactive liver make eye bright, heat-clearing and toxic substances removing is ministerial drug; Contain volatile oil, chrysanthemum glycoside, adenine, choline, stachydrine, aminoacid etc., its preparation has coronary artery dilator, coronary blood flow increasing; Improve the effect of myocardial oxygen consumption, and have hypotensive effect.
Triangular: dispelling wind and heat pathogens, rash are antipruritic, improving acuity of vision and removing nebula, relieving convulsion are ministerial drug, contain a large amount of chitins, protein, aminoacid, organic acid etc., have anticonvulsant action.
Rhizoma Curcumae: promoting diuresis to eliminate damp pathogen, spleen-benefiting mind-tranquilizing are ministerial drug, contain pachyman, pachymic acid, protein, fat, lecithin, choline etc., tool calmness, diuresis, increase myocardial contraction, hypoglycemic activity.
Radix Glycyrrhizae Preparata: regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm are ministerial drug, contain volatile oil, flavonoid glycoside, nobiletin and vitamin B
1, C etc., low dose of heart tonifying, increase cardiac output, coronary artery dilator, can the fortifying fibre protein dissolution, antithrombotic forms, and choleretic effect is arranged.
Therapeutic effect was obvious after most of patients was taken this Chinese medicine, illustrated (for the protection patients ' privacy, saving its name):
Name | Sex | Age | Consultation time | Treatment process | Symptom | The situation of taking medicine |
The temperature certain | The man | 38 years old | In October, 2003 | Suffer from chronic hepatitis B, with occurring leukopenia February behind the interferon therapy, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L accompanies weak | Once took the leucogen, recovery from illness back recurrence is obeyed behind 21 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
Hao | The man | 43 | In JIUYUE, 2000 | Suffer from chronic hepatitis B and caused leukopenia 1 year, once hospital treatment recurred after healing | The PBL counting continues to be lower than normal value 4 * 10 9/ L accompanies weak, happiness lazy moving for sleeping in | Once took leucogen, batilol, recovery from illness back recurrence is obeyed behind 60 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
Lee | The man | 49 | In June, 2002 | Suffer from chronic hepatitis B and cause leukopenia August, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L does not have uncomfortable | Once took the leucogen, recovery from illness back recurrence is obeyed behind 30 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
Grandson | The woman | 36 | In March, 2005 | Suffer from chronic hepatitis B, with occurring leukopenia June behind the interferon therapy, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L accompanies weak | Once took leucogen, DIYU SHENGBAI PIAN, recovery from illness back recurrence is obeyed behind 30 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
Chen | The woman | 33 | In November, 2004 | Suffer from chronic hepatitis B, with occurring leukopenia March behind the interferon therapy, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L accompanies weak | Once took leucogen, batilol, recovery from illness back recurrence is obeyed behind 24 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
[0022]
Lu | The woman | 45 | In February, 2005 | Suffer from chronic hepatitis B and caused leukopenia 13 months, once hospital treatment recurred after healing | The PBL counting continues to be lower than normal value 4 * 10 9/ L does not have uncomfortable | Once took leucogen, DIYU SHENGBAI PIAN, recovery from illness back recurrence is obeyed behind 45 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
The Wang | The man | 41 | In April, 2006 | Suffer from chronic hepatitis B, with occurring leukopenia March behind the interferon therapy, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L accompanies weak | Once took leucogen, DIYU SHENGBAI PIAN, recovery from illness back recurrence is obeyed behind 30 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
Zhang | The man | 39 | In March, 2007 | Suffer from chronic hepatitis B and cause leukopenia May, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L accompanies weak | Once took the leucogen, more back recurrence of convulsion is obeyed behind 21 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
Teng | The man | 47 | In February, 2007 | Suffer from chronic hepatitis B and cause leukopenia March, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L does not have uncomfortable | Once took the leucogen, recovery from illness back recurrence is obeyed behind 21 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in 2 years |
Cao | The man | 33 | In October, 2008 | Suffer from chronic hepatitis B, with occurring leukopenia July behind the interferon therapy, hospital treatment once, more back recurrence | The PBL counting continues to be lower than normal value 4 * 10 9/ L, companion's poor appetite, weak, lazy moving | Once took leucogen, DIYU SHENGBAI PIAN, recovery from illness back recurrence is obeyed behind 45 doses in this Chinese medicine more, follows up a case by regular visits to not recurrence in a year |
The specific embodiment:
Embodiment 1: to make pill is example, gets the Radix Astragali 20 grams, Radix Angelicae Sinensis 7 grams, Radix Codonopsis 12 grams, Radix Rehmanniae Preparata 12 grams, the Radix Paeoniae Alba 12 grams, triangular 12 grams, Rhizoma Curcumae 12 grams, Radix Glycyrrhizae Preparata 3 grams; At first above-mentioned raw material is mixed, clean up; Again cleaned raw material is put into drying baker and dry, grind to form graininess then, reuse 100 purpose sieves sieve ground raw material, and the medicine that granule is little filters out, and for future use, grinding into powder again that granule is big sieved; Then 90 gram Mel are put into pot with the low baking temperature refining, coagulate like the maltosemalt sugar shape, the not order of stirring is burnt; At last refined honey is mixed with above-mentioned medicamental pulverata and rubs by evenly, place half an hour approximately, rub once more by, the honeyed pill of processing about 6 grams gets final product;
Embodiment 2: to make the medicamental pulverata electuary is example, gets the Radix Astragali 28 grams, Radix Angelicae Sinensis 8 grams, Radix Codonopsis 10 grams, Radix Rehmanniae Preparata 10 grams, the Radix Paeoniae Alba 11 grams, triangular 11 grams, Rhizoma Curcumae 11 grams, Radix Glycyrrhizae Preparata 4 grams; At first above-mentioned raw material is mixed, clean up; Again cleaned raw material is put into drying baker and dry, grind to form graininess then, reuse 100 purpose sieves sieve ground raw material; The medicine that granule is little filters out; For future use, grinding into powder again that granule is big sieved, and is that the unit pack gets final product with 6 grams at last;
Embodiment 3: to make capsule is example, gets the Radix Astragali 30 grams, Radix Angelicae Sinensis 8 grams, Radix Codonopsis 10 grams, Radix Rehmanniae Preparata 10 grams, the Radix Paeoniae Alba 10 grams, triangular 10 grams, Rhizoma Curcumae 10 grams, Radix Glycyrrhizae Preparata 5 grams; At first above-mentioned raw material is mixed, clean up; Again cleaned raw material is put into drying baker and dry, grind to form graininess then, reuse 100 purpose sieves sieve ground raw material; The medicine that granule is little filters out; For future use, grinding into powder again that granule is big sieved, and incapsulates with 0.5 gram at last to get final product.
Claims (2)
1. treat chronic hepatitis B or suffer from chronic hepatitis B for one kind, it is characterized in that it is grouped into by following one-tenth: Radix Astragali 20-30g, Radix Angelicae Sinensis 6-10g, triangular 8-12g, Rhizoma Curcumae 8-12g, Radix Rehmanniae Preparata 8-12g, Radix Paeoniae Alba 8-12g, Radix Codonopsis 8-12g, Radix Glycyrrhizae Preparata 3-5g with the leukopenic medicine due to the interferon therapy.
2. treat chronic hepatitis B or suffer from the method for preparing of chronic hepatitis B for one kind, it is characterized in that may further comprise the steps with the leukopenic medicine due to the interferon therapy:
1) cleans: raw material Radix Astragali 20-30g, Radix Angelicae Sinensis 6-10g, triangular 8-12g, Rhizoma Curcumae 8-12g, Radix Rehmanniae Preparata 8-12g, Radix Paeoniae Alba 8-12g, Radix Codonopsis 8-12g, Radix Glycyrrhizae Preparata 3-5g are mixed, clean up with clear water;
2) sieve: cleaned raw material is put into drying baker dry, grind into powder then, reuse 100 purpose sieves sieve raw material, and the medicamental pulverata that granule is little filters out, and for future use, grinding into powder again that granule is big sieved;
3) refining Mel: Mel is put into pot with the low baking temperature refining, coagulate like the maltosemalt sugar shape, the not order of stirring is burnt, and the addition of Mel is 1 times of raw-material weight;
4) process pill: the Mel of refining is mixed with above-mentioned medicamental pulverata rubs by evenly, placement half an hour, rub once more by, the honeyed pill of processing 6g gets final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101288342A CN102166329B (en) | 2010-03-17 | 2010-03-17 | Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101288342A CN102166329B (en) | 2010-03-17 | 2010-03-17 | Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102166329A CN102166329A (en) | 2011-08-31 |
CN102166329B true CN102166329B (en) | 2012-08-22 |
Family
ID=44487772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101288342A Expired - Fee Related CN102166329B (en) | 2010-03-17 | 2010-03-17 | Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102166329B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906244B (en) * | 2015-07-02 | 2017-11-10 | 赵成茂 | A kind of Chinese medicine composition for treating leukopenia |
CN111214633A (en) * | 2020-03-09 | 2020-06-02 | 耿禄 | Formula for treating infectious hepatitis B |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101357219A (en) * | 2008-09-04 | 2009-02-04 | 兰州佛慈制药股份有限公司 | Medicine for treating chronic hepatitis b |
CN101385842A (en) * | 2008-10-14 | 2009-03-18 | 王林兴 | Medicine for treating chronic hepatitis b and preparation method thereof |
-
2010
- 2010-03-17 CN CN2010101288342A patent/CN102166329B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101357219A (en) * | 2008-09-04 | 2009-02-04 | 兰州佛慈制药股份有限公司 | Medicine for treating chronic hepatitis b |
CN101385842A (en) * | 2008-10-14 | 2009-03-18 | 王林兴 | Medicine for treating chronic hepatitis b and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
钟有添等.中医药治疗病毒性乙型肝炎研究进展.<<赣南医学院学报>>.2004,第24卷(第2期),224-227. * |
Also Published As
Publication number | Publication date |
---|---|
CN102166329A (en) | 2011-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102293927B (en) | Compound Chinese medicinal preparation with antifatigue and antioxidation effects, and preparation method thereof | |
CN105055606A (en) | Medicine for treating influenza | |
CN101129588A (en) | Instant powder for conjunctivitis | |
CN101926882A (en) | Medicinal composition for treating cancer and preparation methods thereof | |
CN104491695A (en) | Pharmaceutical composition for treating chloasma | |
CN104055935B (en) | It is a kind of to cooperate with the Chinese medicine composition for improving immunity | |
CN102166329B (en) | Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof | |
CN108635389A (en) | A kind of preparation method of Chinese medicine preparation and its electuary that treating diabetes B | |
CN108815448B (en) | Traditional Chinese medicine granules for treating chronic colitis | |
CN105477465A (en) | Chinese herb preparation with liver protection function and preparing technology of Chinese herb preparation | |
CN102188675B (en) | Medicine for treating peripheral vertigo, and preparation thereof | |
CN110624060A (en) | Traditional Chinese medicine preparation for treating infantile diarrhea and preparation method thereof | |
CN100358552C (en) | Medicine for treating amblyopia and its preparing method | |
CN104435685A (en) | Medicine for treating xerophthalmia and preparation method thereof | |
CN103920020A (en) | Traditional Chinese medicine composition for treating headache and preparation method thereof | |
CN102764385A (en) | Medicine for treating venereophobia and application of medicine | |
CN112076276B (en) | Pharmaceutical composition for treating allergic rhinitis and preparation method thereof | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN105327003A (en) | Traditional Chinese medicine for treating cardiovascular diseases and preparation method thereof | |
CN1449782A (en) | Compound cactsu antivirus preparation | |
CN109876101A (en) | A kind of Chinese medicine composition that treating goat, Chinese materia medica preparation and preparation method | |
CN104888080A (en) | Traditional Chinese medicine composition for treating insomnia | |
CN104491717A (en) | Medicament for treating mammary hyperplasia | |
CN104523866A (en) | Convulsion and spasm relieving preparation for treating infantile febrile convulsion and preparation method thereof | |
CN102631493B (en) | Health care composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120822 Termination date: 20130317 |